Zhang H - Search Results

1

Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.

Zhang YH, Yue ZJ, Zhang H, Tang GS, Wang Y, Liu JM. Zhang YH, et al. Among authors: zhang h. Eur J Pharm Biopharm. 2010 Nov;76(3):371-5. doi: 10.1016/j.ejpb.2010.08.011. Epub 2010 Sep 9. Eur J Pharm Biopharm. 2010. PMID: 20816959

2

Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.

Zhang YH, Zhang H, Liu JM, Yue ZJ. Zhang YH, et al. Among authors: zhang h. Med Oncol. 2011 Sep;28(3):901-6. doi: 10.1007/s12032-010-9531-2. Epub 2010 Apr 16. Med Oncol. 2011. PMID: 20396980

3

Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.

Zhang H, Gao S. Zhang H, et al. Int J Pharm. 2007 Feb 1;329(1-2):122-8. doi: 10.1016/j.ijpharm.2006.08.027. Epub 2006 Aug 30. Int J Pharm. 2007. PMID: 17000068

4

Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.

Huang J, Zhang H, Yu Y, Chen Y, Wang D, Zhang G, Zhou G, Liu J, Sun Z, Sun D, Lu Y, Zhong Y. Huang J, et al. Among authors: zhang g, zhang h. Biomaterials. 2014 Jan;35(1):550-66. doi: 10.1016/j.biomaterials.2013.09.089. Epub 2013 Oct 15. Biomaterials. 2014. PMID: 24135268

5

Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.

Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y. Zhang H, et al. Among authors: zhang g. Int J Pharm. 2008 Mar 3;351(1-2):244-9. doi: 10.1016/j.ijpharm.2007.10.004. Epub 2007 Oct 11. Int J Pharm. 2008. PMID: 18024022

6

In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.

Liu Q, Zhang H, Zhou G, Xie S, Zou H, Yu Y, Li G, Sun D, Zhang G, Lu Y, Zhong Y. Liu Q, et al. Among authors: zhang g, zhang h. Int J Pharm. 2010 Sep 15;397(1-2):122-9. doi: 10.1016/j.ijpharm.2010.07.015. Epub 2010 Jul 25. Int J Pharm. 2010. PMID: 20650309

7

Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.

Gao J, Zhong W, He J, Li H, Zhang H, Zhou G, Li B, Lu Y, Zou H, Kou G, Zhang D, Wang H, Guo Y, Zhong Y. Gao J, et al. Among authors: zhang d, zhang h. Int J Pharm. 2009 Jun 5;374(1-2):145-52. doi: 10.1016/j.ijpharm.2009.03.018. Epub 2009 Mar 24. Int J Pharm. 2009. PMID: 19446771

8

Preparation of glucagon-like peptide-1 loaded PLGA microspheres: characterizations, release studies and bioactivities in vitro/in vivo.

Yin D, Lu Y, Zhang H, Zhang G, Zou H, Sun D, Zhong Y. Yin D, et al. Among authors: zhang g, zhang h. Chem Pharm Bull (Tokyo). 2008 Feb;56(2):156-61. doi: 10.1248/cpb.56.156. Chem Pharm Bull (Tokyo). 2008. PMID: 18239299 Free article.

9

Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.

Chen H, Gao J, Lu Y, Kou G, Zhang H, Fan L, Sun Z, Guo Y, Zhong Y. Chen H, et al. Among authors: zhang h. J Control Release. 2008 Jun 24;128(3):209-16. doi: 10.1016/j.jconrel.2008.03.010. Epub 2008 Mar 19. J Control Release. 2008. PMID: 18450313

10

Exenatide-loaded PLGA microspheres with improved glycemic control: in vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats.

Xuan J, Lin Y, Huang J, Yuan F, Li X, Lu Y, Zhang H, Liu J, Sun Z, Zou H, Chen Y, Gao J, Zhong Y. Xuan J, et al. Among authors: zhang h. Peptides. 2013 Aug;46:172-9. doi: 10.1016/j.peptides.2013.06.005. Epub 2013 Jun 14. Peptides. 2013. PMID: 23770254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129,628 results

Search Page

Filters